Polysaccharide‐Based Stimulus‐Responsive Nanomedicines for Combination Cancer Immunotherapy
2023 · Small · 55 citations
https://doi.org/10.1002/smll.202206211
Q
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
23
Papers
242
Citations
5
h-index
5
i10-index
Qiuxia Li is an academic researcher from First Affiliated Hospital of GuangXi Medical University. The author has contributed to research in topics: COVID-19 and Mental Health & COVID-19 Clinical Research Studies & Long-Term Effects of COVID-19. The author has an h-index of 5, co-authored 20 publications.
ORCID: 0009-0000-8808-2036Papers by this author
worksConstruction and validation of a nomogram to predict the overall survival of small cell lung cancer: a multicenter retrospective study in Shandong province, China
2023 · BMC Cancer · 5 citations
https://doi.org/10.1186/s12885-023-11692-7
Pullulan-stabilized gliadin nanocomplexes loaded with astragaloside IV: Fabrication, characterization and treatment of ulcerative colitis
2026 · Carbohydrate Polymers · 0 citations
https://doi.org/10.1016/j.carbpol.2026.124899
Application study of an artificial intelligence and big data-based personalized chronic disease management model for diabetes patients
2026 · Frontiers in Public Health · 0 citations
https://doi.org/10.3389/fpubh.2026.1735295
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat